15,000 AXP shares to be sold under Rule 144 notice filing

Rhea-AI Filing Summary

A holder of AXP common stock has filed notice to sell 15,000 shares under Rule 144. The planned sale has an indicated aggregate market value of $5,348,698.50, to be executed through Morgan Stanley Smith Barney LLC on the NYSE around February 9, 2026.

The shares come from multiple grants of restricted stock vesting under a registered plan between January 2024 and February 2026, including a large vesting of 10,318 shares on February 1, 2026. The issuer had 686,614,005 shares of common stock outstanding when this notice was prepared.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	15000	5348698.50	686614005	02/09/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/12/2024	Restricted stock vesting under a registered plan	Issuer			27	08/12/2024	Not Applicable
Common	01/28/2025	Restricted stock vesting under a registered plan	Issuer			4003	01/28/2025	Not Applicable
Common	05/13/2024	Restricted stock vesting under a registered plan	Issuer			27	05/13/2024	Not Applicable
Common	11/11/2024	Restricted stock vesting under a registered plan	Issuer			22	11/11/2024	Not Applicable
Common	02/01/2026	Restricted stock vesting under a registered plan	Issuer			10318	02/01/2026	Not Applicable
Common	01/28/2024	Restricted stock vesting under a registered plan	Issuer			588	01/28/2024	Not Applicable
Common	02/12/2024	Restricted stock vesting under a registered plan	Issuer			15	02/12/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does this Form 144 filing for AXP disclose?

This Form 144 discloses a planned sale of 15,000 AXP common shares under Rule 144. The sale is to be executed through Morgan Stanley Smith Barney LLC on the NYSE, with an indicated aggregate market value of $5,348,698.50.

How many AXP shares are planned for sale and on what exchange?

The notice covers a planned sale of 15,000 AXP common shares. The filer intends to sell these shares on the New York Stock Exchange (NYSE) using Morgan Stanley Smith Barney LLC as broker, under the provisions of Rule 144.

What is the aggregate market value of the AXP shares in this Form 144?

The filing states an aggregate market value of $5,348,698.50 for the 15,000 AXP common shares to be sold. This figure reflects the estimated market value at the time the notice was prepared, not necessarily the final sale proceeds.

How were the AXP shares in this Form 144 acquired?

The shares were acquired through restricted stock vesting under a registered plan. Multiple vesting dates are listed from January 2024 through February 2026, including a significant vesting of 10,318 shares on February 1, 2026 directly from the issuer.

How many AXP shares were outstanding when this Form 144 was prepared?

The notice reports that 686,614,005 AXP common shares were outstanding at the time of preparation. This figure provides context for the 15,000-share planned sale but does not indicate any new issuance of shares.

Does the Form 144 mention recent AXP share sales by the same holder?

The document includes a section for securities sold during the past three months. In this excerpt, no prior sales are listed, indicating no reported AXP share sales by this holder in that lookback period within the provided content.